Collaborating to Develop A New Roadmap for Personalized Medicine
THI’s Cardiomyocyte Renewal Laboratory takes a closer look at the gene expression landscape of congenital heart disease Researchers in the...
THI’s Cardiomyocyte Renewal Laboratory takes a closer look at the gene expression landscape of congenital heart disease Researchers in the...
Scientists Develop a Roadmap to Future Personalized Medicine for Heart Defects that Develop Before Birth HOUSTON, TX – (June...
Texas Heart Institute’s Rich Gang Li, PhD, recently earned the award for “Best Oral Presentation” for his platform talk at...
The impact of a scientific article is often described in terms of how many times the article has been cited...
HOUSTON, TX (DECEMBER 7, 2021) – The Texas Heart Institute is pleased to announce that Dr. Darren G. Woodside, Senior...
The New Paper Follows Closely on the Heels of a Related Publication on Cardiomyocyte Renewal Following a Heart Attack ...
Patients suffering from heart failure have very limited treatment options, and up to this point, it had essentially been impossible...
Published in Science Translational Medicine – A Revolutionary New Game Plan for Treating Individuals Following a Heart Attack HOUSTON, TX...
More than 450 children undergo a heart transplant in the United States each year. Despite incredible advances in the field...
Houston, TX (February 11, 2021) – The Texas Heart Institute is pleased to announce that Dr. James Martin, Director of its...
Texas Heart Institute has been at the forefront of cardiovascular discovery and innovation since its formation. It continues to relentlessly...
Over the past six decades, physicians and scientists at the Texas Heart Institute have worked diligently with colleagues around the...
You can see how this popup was set up in our step-by-step guide: https://wppopupmaker.com/guides/auto-opening-announcement-popups/
Visit U.S. News & World Report